Woodline Partners’s European Biotech Acquisition Corp. Class A Ordinary Shares EBAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-375,000
| Closed | -$3.79M | – | 910 |
|
|
2022
Q4 | $3.79M | Buy |
375,000
+100,000
| +36% | +$1.01M | 0.05% | 358 |
|
|
2022
Q3 | $2.72M | Hold |
275,000
| – | – | 0.04% | 420 |
|
|
2022
Q2 | $2.69M | Hold |
275,000
| – | – | 0.04% | 384 |
|
|
2022
Q1 | $2.68M | Hold |
275,000
| – | – | 0.04% | 337 |
|
|
2021
Q4 | $2.67M | Hold |
275,000
| – | – | 0.04% | 382 |
|
|
2021
Q3 | $2.67M | Hold |
275,000
| – | – | 0.04% | 366 |
|
|
2021
Q2 | $2.65M | Buy |
+275,000
| New | +$2.65M | 0.05% | 313 |
|